| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 128.69B | 129.43B | 129.81B | 129.14B | 132.78B | 138.22B |
| Gross Profit | 32.83B | 30.42B | 31.86B | 33.28B | 30.10B | 34.60B |
| EBITDA | 10.44B | 13.18B | 11.66B | 14.02B | 12.15B | 3.69B |
| Net Income | 3.48B | 8.26B | 4.09B | 7.54B | 5.19B | -3.66B |
Balance Sheet | ||||||
| Total Assets | 160.53B | 180.47B | 164.51B | 171.10B | 168.18B | 177.53B |
| Cash, Cash Equivalents and Short-Term Investments | 31.11B | 31.56B | 33.07B | 38.66B | 38.17B | 45.55B |
| Total Debt | 18.09B | 37.37B | 18.84B | 18.34B | 25.99B | 32.86B |
| Total Liabilities | 66.13B | 90.28B | 70.34B | 73.79B | 82.24B | 92.92B |
| Stockholders Equity | 91.66B | 87.06B | 91.36B | 93.89B | 82.82B | 81.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.08B | 1.99B | 7.64B | -1.52B | 13.30B |
| Operating Cash Flow | 0.00 | 8.93B | 9.84B | 14.24B | 4.00B | 18.44B |
| Investing Cash Flow | 0.00 | -15.06B | -8.03B | -4.85B | 1.71B | -3.91B |
| Financing Cash Flow | 0.00 | 2.91B | -7.75B | -9.49B | -13.98B | -6.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥3.87T | 18.51 | 1.37% | 2.29% | 2.77% | 500.36% | |
69 Neutral | ¥173.91B | 9.04 | 13.53% | 1.34% | -3.63% | -14.77% | |
62 Neutral | ¥86.02B | 9.53 | ― | 1.99% | -0.29% | 119.59% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥7.76T | -69.04 | 4.25% | 1.99% | -7.70% | -39.06% | |
56 Neutral | ¥19.11T | -5.95 | 14.45% | 0.55% | -12.56% | -119.49% | |
49 Neutral | ¥378.13B | 5.68 | ― | ― | -13.33% | ― |